Cancer Biomarkers

A cancer growth biomarker alludes to a substance or procedure that is demonstrative of the nearness of disease in the body. A biomarker might be an atom discharged by a tumour or a particular reaction of the body to the nearness of malignancy. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for cancer growth determination, visualization, and the study of disease transmission. Such biomarkers is tested in non-obtrusively gathered bio fluids like blood or liquid body substance.

A number of quality and protein based biomarkers have just been utilized eventually in tolerant consideration; including,

AFP (Liver Cancer)

BCR-ABL (Chronic Myeloid Leukaemia)

BRCA1/BRCA2 (Breast/Ovarian Cancer)

BRAF V600E (Melanoma/Colorectal Cancer)

 

  • Diagnostic
  • Prognostic
  • Predictive

Related Conference of Cancer Biomarkers

December 07-08, 2020

2nd Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
December 10-11, 2020

4th Annual Conference on Skin Cancer and Dermatology

Abu Dhabi, UAE
February 25-26, 2021

5th Global summit on Cancer Science and Oncology

Vienna, Austria
April 05-06, 2021

2 nd Global Summit on Oncology and Hematology

Berlin, Germany
April 28-29, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
May 17-18, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
May 17-18, 2021

11th World Congress on Breast Cancer & Therapies

Prague, Czech Republic
June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Australia
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
August 13-14, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany

Cancer Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in